NSE filing, NSE: BALAXI. Summary written from the filing by ALFA Finder's alert engine.
Balaxi Pharmaceuticals Ltd: key numbers
- Share price
- ₹19.15
- Market cap
- ₹105.7 Cr
- Revenue (annual)
- ₹270.2 Cr
- Net profit (annual)
- ₹1.42 Cr
- P/E (TTM)
- 43.6×Sector 45.9×
- Promoter holding
- 65.99%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balaxi Pharmaceuticals Ltd
All →Balaxi Pharmaceuticals Board Meeting Date
Balaxi Pharmaceuticals will meet on 12 November 2026 to approve unaudited half-year results. The trading window stays closed until 14 November 2026.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals Limited reported nil activity regarding the re-lodgement of physical share transfer requests for the period ended September 2026.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals reported nil activity regarding the re-lodgement of physical share transfer requests for August 2026. This is a routine regulatory compliance filing.
Balaxi Pharmaceuticals Business Update
Balaxi Pharmaceuticals has received WHO-GMP certification for its first pharmaceutical formulation manufacturing facility in Telangana. The facility has commenced manufacturing initially approved products for international markets.
Balaxi Pharmaceuticals Management Change
Balaxi Pharmaceuticals Limited shareholders approved the re-appointment of Ms. Akshita Ostwal as an Independent Director for a second five-year term starting September 5, 2026.
Balaxi Pharmaceuticals Annual General Meeting
Balaxi Pharmaceuticals Limited held its 83rd Annual General Meeting on August 24, 2026. Shareholders voted on financial statements and director re-appointments during the proceedings.
Other price movement clarification announcements
All →Black Opal Consultants Price Movement Clarification
Black Opal Consultants clarified to BSE on recent share price movement. It says no pending price-sensitive information exists and the move appears market-driven.
SJP Ultrasonics Price Movement Clarification
SJP Ultrasonics clarified to BSE that it is unaware of any undisclosed price-sensitive information behind a recent significant share price movement. It cannot comment on the causes, which it attributes to market factors.
Filtron Engineers Price Movement Clarification
Filtron Engineers says its recent share price movement is market-driven and no price-sensitive information is pending. It replies to a BSE query dated 29 October 2026.
Century Business Media Price Movement Clarification
Century Business Media is unaware of any reason for its recent share price movement. It attributes the move to market conditions.
Suzlon Energy Price Movement Clarification
Suzlon Energy reported a material price movement on 30 Oct 2026. The company stated no identifiable event or media report triggered the move.
NMS Global Price Movement Clarification
NMS Global responded to BSE's October 27 price-movement query, stating it is unaware of any undisclosed material event. The price move appears market-driven.